What is the recommended routine pediatric vaccination schedule in Egypt?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Routine Pediatric Vaccination Schedule in Egypt

Egypt follows a comprehensive immunization schedule that includes BCG at birth, followed by DTP, OPV, and Hepatitis B vaccines starting at 2 months of age, with measles vaccine at 9 months, based on the WHO Eastern Mediterranean Region recommendations. 1

Core Vaccination Schedule

Birth

  • BCG vaccine is administered at birth in Egypt 1
  • Hepatitis B vaccine first dose should be given at birth (within 24 hours) to prevent vertical transmission, though Egypt's official schedule begins at 2 months 2, 1

2,4, and 6 Months

  • DTP (Diphtheria-Tetanus-Pertussis): Three primary doses 1
  • OPV (Oral Polio Vaccine): Three primary doses given simultaneously with DPT 1
  • Hepatitis B: Egypt adopted a schedule at 2,4, and 6 months of age in 1992 3

Important caveat: Research from Egyptian children shows that the 2-4-6 month hepatitis B schedule produces lower long-term antibody levels compared to schedules with longer intervals between doses 4, 3. A schedule of 2,4, and 9 months produces significantly higher geometric mean titers (1,492 mIU/ml vs 306 mIU/ml) 4.

9-12 Months

  • Measles vaccine: Given at 9-12 months of age as monovalent measles vaccine in most cases 1

Booster Doses

  • Fourth DTP dose: Egypt uses a fourth dose of DPT vaccine in the second year of life or later 1
  • Additional OPV dose: An additional dose in the second year of life is recommended 1

Special Considerations for Egypt

Hepatitis B Optimization

The evidence strongly suggests Egypt should consider modifying its hepatitis B schedule. Studies in Egyptian neonates demonstrate that delaying the third dose until 9 months produces 96% good-to-excellent immune response versus 85% with the 2-4-6 month schedule 4. Additionally, long-term follow-up shows rapid decline in antibody levels with the current 2-4-6 month schedule, leading researchers to recommend booster inoculations and a new schedule at 1,2, and 9 months 3.

Tuberculosis Control

Egypt continues BCG vaccination at birth as part of WHO TB control policy, which has successfully reduced TB incidence by 50% over 20 years (from 34 to 17 cases per 100,000 population) 5. BCG should remain part of the routine schedule given Egypt's ongoing TB burden 5.

Maternal Hepatitis B Status

  • If mother is HBsAg-positive: Hepatitis B vaccine plus HBIG must be given within 12 hours of birth, with subsequent doses at 1 and 6 months 6
  • If mother's status is unknown: Administer vaccine within 12 hours and determine status urgently 6

Common Pitfalls to Avoid

  • Delaying birth dose of Hepatitis B beyond 24 hours significantly reduces effectiveness in preventing vertical transmission 2
  • Not following minimum intervals between doses can result in suboptimal immune response 2
  • Failure to complete multi-dose series compromises protective efficacy 2
  • The short 2-month interval between second and third hepatitis B doses in Egypt's current schedule is less desirable for long-term protection 3

Immunocompromised Children

Live vaccines (MMR, varicella) are contraindicated in severely immunocompromised patients, including HIV-infected children who require special vaccination schedule considerations 2.

References

Guideline

Immunization Schedule in India

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Long-term immunogenicity and efficacy of a recombinant hepatitis B vaccine in Egyptian children.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.